Skip to main content
SpringerLink
Log in

Cysteine proteinases and metastasis

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Cysteine proteinases are a subclass of endopeptidases which require activation by thiol reagents. A tumor cysteine proteinase which appears to be related to lysosomal cathepsin B has been implicated in the ability of tumor cells to invade the extracellular matrix and to metastasize to secondary sites. Lysosomal cathepsin B can degrade such components of the extracellular matrix as collagen, fibronectin and proteoglycans. Activity of this cathepsin B-like cysteine proteinase (CB) has been correlated with tumor malignancy in a number of tumor lines yet not in all tumor lines studied. CB activity in tumors seems to be associated with the viable tumor cells, probably with the plasma membrane of these tumor cells. CB activity has been measured in the sera, urine, ascites fluid and pancreatic fluid of tumor-bearing patients. CB is released from tumor explants and tumor cells in vitro as well as from normal subcutaneous tissue exposed to tumor-conditioned medium. Cathepsin B from normal tissues is rapidly inactivated above pH 7.0. Therefore, CB in tumor cell membranes or released from tumor cells (or from host cells in response to tumor cells) may not possess proteolytic activity at neutral pH and thus may not facilitate tumor cell invasion. However, CB exhibits enhanced stability at neutral or slightly alkaline pH's. There is not yet definitive proof that CB plays a role in tumor invasion and metastasis. There is, however, an increasing body of correlative evidence relating CB activity and tumor malignancy. This correlative evidence plus preliminary evidence that tumor CB can degrade components of the extracellular matrix in vitro suggests that CB may be one proteinase active in a proteolytic cascade resulting in tumor invasion and metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jones PA, De Clerck YA: Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Rev 1: 289–317, 1982.

    Google Scholar 

  2. Recklies AD, Poole AR: Proteolytic mechanisms of tissue destruction in tumor growth and metastasis. In: Weiss L, Gilbert HA (eds) Liver metastasis. GK Hall, Boston, 1982, pp 77–95.

    Google Scholar 

  3. Mullins DE, Rohrlich ST: The role of proteinases in cellular invasiveness. Biochem Biophys Acta 695: 177–214, 1983.

    Google Scholar 

  4. Liotta LA, Rao CN, Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 49: 636–649, 1983.

    Google Scholar 

  5. Pauli BU, Schwartz DE, Thonar EJM, Kuettner KE: Tumor invasion and host extracellular matrix. Cancer Metastasis Rev 2: 129–152, 1983.

    Google Scholar 

  6. Liotta LA, Thorgeirsson UP, Garbisa S: Role of collagenases in tumor cell invasion. Cancer Metastasis Rev 1: 277–288, 1982.

    Google Scholar 

  7. Hozumi M, Ogawa M, Sugimura T, Kakeuchi T, Umezawa H: Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Res 32: 1725–1728, 1972.

    Google Scholar 

  8. Kennedy AR, Little JB: Protease inhibitors suppress radiation-induced malignant transformation in vitro. Nature (London) 276: 825–826, 1978.

    Google Scholar 

  9. Kennedy AR, Little JB: Effects of protease inhibitors on radiation transformation in vitro. Cancer Res 41: 2103–2108, 1981.

    Google Scholar 

  10. Borek C, Miller R, Pain C, Troll W: Conditions for inhibiting and enhancing effects of the protease inhibitor antipain on x-ray induced neoplastic transformation in hamster and mouse cells. Proc Natl Acad Sci USA 76: 1800–1803, 1979.

    Google Scholar 

  11. Goetz IE, Weinstein C, Roberts E: Effects of protease inhibitors on growth of hamster tumor cells in culture. Cancer Res 32: 2469–2474, 1972.

    Google Scholar 

  12. Schnebli HP, Burger MM: Selective inhibition of growth of transformed cells by protease inhibitors. Proc Natl Acad Sci USA 69: 3825–3827, 1972.

    Google Scholar 

  13. Langer R, Brem H, Falterman K, Klein M, Folkman J: Isolation of a cartilage factor that inhibits tumor neovascularization. Science 193: 70–72, 1976.

    Google Scholar 

  14. Lee A, Langer R: Shark cartilage contains inhibitors of tumor angiogenesis. Science 221: 1185–1187, 1983.

    Google Scholar 

  15. Burger MM: Proteolytic enzymes initiating cell division and escape from contact inhibition of growth. Nature (London) 227: 170–171, 1970.

    Google Scholar 

  16. Rubin H: Overgrowth stimulating factor released from Rous sarcoma cells. Science 167: 1271–1272, 1970.

    Google Scholar 

  17. Barrett AJ: The many forms and functions of cellular proteinases. Fed Proc Fed Am Soc Exp Biol 39: 9–14, 1980.

    Google Scholar 

  18. Barrett AJ, McDonald JK: Mammalian proteases. Academic Press, New York, Vol. 1, 1980.

    Google Scholar 

  19. Neurath H: Evolution of proteolytic enzymes. Science 224: 350–357, 1984.

    Google Scholar 

  20. Takio K, Towatari T, Katunuma N, Teller DC, Titani K: Homology of amino acid sequences of rat liver cathepsins B and H with that of papain. Proc Natl Acad Sci USA 80: 3666–3670, 1983.

    Google Scholar 

  21. Suzuki K, Hayashi H, Hayashi T, Iwai K: Amino acid sequence around the active site cysteine residue of calcium activated neutral protease (CANP). FEBS Lett 152: 67–70, 1983.

    Google Scholar 

  22. Bajkowski AS, Frankfater A: Steady state kinetic evidence for an acyl-enzyme intermediate in reactions catalyzed by bovine spleen cathepsin B. J Biol Chem 258: 1645–1649, 1983.

    Google Scholar 

  23. Bajkowski AS, Frankfater A: The pH dependency of bovine spleen cathepsin B catalyzed transfer of N-benzyloxycarbonyl-L-lysine from p-nitrophenol to water and dipeptide nucleophiles. Comparisons with papain. J Biol Chem 258: 1650–1655, 1983.

    Google Scholar 

  24. Katunuma N, Kominami E: Structures and functions of lysosomal thiol proteinases and their endogenous inhibitor. Curr Topics Cell Regulation 22: 71–101, 1983.

    Google Scholar 

  25. Mort JS, Recklies AD, Poole AR: Characterization of a thiol proteinase secreted by malignant human breast tumors. Biochim Biophys Acta 614: 134–143, 1980.

    Google Scholar 

  26. Barrett AJ: Human cathepsin B1. Purification and some properties of the enzyme. Biochem J 131: 809–822, 1973.

    Google Scholar 

  27. Schwartz WN, Bird JWC: Degradation of myofibrillar proteins by cathepsins B and D. Biochem J 167: 811–820, 1977.

    Google Scholar 

  28. Noda T, Isogai K, Hayashi H, Katunuma N: Susceptibilities of various myofibrillar proteins to cathepsin B and morphological alteration of isolated myofibrils by this enzyme. J Biochem (Tokyo) 90: 371–379, 1981.

    Google Scholar 

  29. McKay MJ, Offermann MK, Barrett AJ, Bond JS: Action of human liver cathepsin B on the oxidized insulin B chain. Biochem J 213: 467–471, 1983.

    Google Scholar 

  30. Aronson NN, Barrett AJ: The specificity of cathepsin B. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism. Biochem J 171: 759–765, 1978.

    Google Scholar 

  31. Bond JS, Barrett AJ: Degradation of fructose-1,6-biphosphate aldolase by cathepsin B. A further example of peptidyldipeptidase activity of this proteinase. Biochem J 189: 17–25, 1980.

    Google Scholar 

  32. Morrison RIG, Barrett AJ, Dingle JT: Cathepsins B1 and D action on human cartilage proteoglycans. Biochim Biophys Acta 302: 411–419, 1973.

    Google Scholar 

  33. Burleigh MC, Barrett AJ, Lazarus GS: Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem J 137: 387–398, 1974.

    Google Scholar 

  34. Etherington DS, Evans PJ: The action of cathepsin B and collagenolytic cathepsin in the degradation of collagen. Acta Biol Med Germ 36: 1555–1563, 1977.

    Google Scholar 

  35. Eeckhout Y, Vaes G: Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 166: 21–31, 1977.

    Google Scholar 

  36. Sylven B: Cellular detachment by purified lysosomal cathepsin B. Eur J Cancer 4: 559–562, 1968.

    Google Scholar 

  37. Schwartz WN, Barrett AJ: Human cathepsin H. Biochem J 191: 487–497, 1980.

    Google Scholar 

  38. Kirschke H, Langner J, Wiederanders B, Ansorge S, Bohley P: Cathepsin L. A new proteinase from rat liver lysosomes. Eur J Biochem 74: 293–301, 1977.

    Google Scholar 

  39. Kirschke H, Kembhavi AA, Bohley P, Barrett AJ: Action of rat liver cathepsin L on collagen and other substrates. Biochem J 201: 367–372, 1982.

    Google Scholar 

  40. Hathaway DR, Werth DK, Haeberle JR: Limited autolysis reduces the Ca2+ requirement of a smooth muscle Ca2+-activated protease. J Biol Chem 257: 9072–9077, 1982.

    Google Scholar 

  41. Wheelock MJ: Evidence for two structurally different forms of skeletal muscle Ca2+-activated protease. J Biol Chem 257: 12471–12474, 1982.

    Google Scholar 

  42. Yoshimura N, Kikuchi T, Sasaki T, Kitahara A, Hatanaka M, Murachi T: Two distinct Ca2+ proteases (calpain I and calpain II) purified concurrently by the same method from rat kidney. J Biol Chem 258: 8883–8889, 1983.

    Google Scholar 

  43. Malik MN, Fenko MD, Iqbal K, Wisniewski HM: Purification and characterization of two forms of Ca2+-activated neutral protease from calf brain. J Biol Chem 258: 8955–8962, 1983.

    Google Scholar 

  44. Ishiura S: Calcium-dependent proteolysis in living cells. Life Sci 29: 1079–1087, 1981.

    Google Scholar 

  45. Adnot S, Poirier-Dupuis M, Franks DJ, Hamet P: Stimulation of rat platelet adenylate cyclase by an endogenous calcium-dependent protease-like activity. J Cyclic Nucleotide Res 8: 103–118, 1982.

    Google Scholar 

  46. Gates RE, King LE: Proteolysis of the epidermal growth factor receptor by endogenous calcium-activated neutral protease from rat liver. Biochem Biophys Res Commun 113: 255–261, 1983.

    Google Scholar 

  47. Nelson WJ, Traub P: Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins. Mol Cell Biol 3: 1146–1146, 1983.

    Google Scholar 

  48. Ishiura S, Nonaka I, Sugita H: Calcium-activated neutral protease: its degradative role in muscle cells. In: Ebashi S (ed) Muscular dystrophy. Univ of Tokoyo Press, Tokyo, 1982, pp 265–282.

    Google Scholar 

  49. Tsujinaka T, Sakon M, Kambayashi J, Kosaki G: Cleavage of cytoskeletal proteins by two forms of Ca activated neutral proteases in human platelets. Thromb Res 28: 149–156, 1982.

    Google Scholar 

  50. Yoshida N, Weksler B, Nachman R: Purification of human platelet calcium-activated protease. Effect on platelet and endothelial function. J Biol Chem 258: 7168–7174, 1983.

    Google Scholar 

  51. Bosmann HB, Hall TC: Enzyme activity in invasive tumors of human breast and colon. Proc Natl Acad Sci USA 71: 1833–1837, 1974.

    Google Scholar 

  52. Holmberg B: On the in vitro release of cytoplasmic enzymes from ascites tumor cells as compared with strain L cells. Cancer Res 219: 1386–1393, 1961.

    Google Scholar 

  53. Sylven B, Ottoson R, Revesz L: The content of dipeptidases and acid proteinases in the ascitic fluid of mice with ascites tumors. Br J Cancer 13: 551–565, 1959.

    Google Scholar 

  54. Sylven B, Snellman O, Strauli P: Immunofluorescent studies on the occurrence of cathepsin B1 at tumor cell surfaces. Virchows Arch B Cell Pathol 17: 97–112, 1974.

    Google Scholar 

  55. Dobrossy L, Pavelic ZP, Vaughn M, Porter N, Bernacki RJ: Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis. Cancer Res 40: 3281–3285, 1980.

    Google Scholar 

  56. Weiss L: Some mechanisms involved in cancer cell detachment by necrotic material. Int J Cancer 22: 196–203, 1978.

    Google Scholar 

  57. Sylven B, Malmgren H: The histological distribution of proteinase and peptidase activity in solid mouse tumor transplants. A histochemical study on the enzymic characteristics of the different tumor cell types. Acta Radiol 154: 1–124 (Suppl), 1957.

    Google Scholar 

  58. Shamberger RJ, Rudolph G: Increase of lysosomal enzymes in skin cancer. Nature (London) 213: 617–618, 1967.

    Google Scholar 

  59. Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD: Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res 42: 980–986, 1982.

    Google Scholar 

  60. McLaughlin MEH, Liener IE, Wang N: Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma. Clin Exp Metastasis 1: 359–372, 1983.

    Google Scholar 

  61. Olstein AD, Liener IE: Comparative studies of mouse liver cathepsin B and an analogous tumor thiol proteinase. J Biol Chem 258: 11049–11056, 1983.

    Google Scholar 

  62. Sloane BF, Bajkowski AS, Day NA, Honn KV, Crissman JD: Purification and properties of a cathepsin B-like enzyme from human tumors: comparison with cathepsin B isolated from human liver and spleen (Abstract). Proc Am Assoc Cancer Res 25: 4, 1984.

    Google Scholar 

  63. Sloane BF, Dunn JR, Honn KV: Lysosomal cathepsin B: correlation with metastatic potential. Science 212: 1151–1153, 1981.

    Google Scholar 

  64. Ryan R, Crissman JD, Honn KV, Sloane BF: Association of cysteine proteinase activities with viable tumor cells isolated from rodent primary subcutaneous tumors (Abstract). Proc Am Assoc Cancer Res 25: 4, 1984.

    Google Scholar 

  65. Crissman J, Sloane B, Ryan R: Correlation of cathepsin B and metastatic potential in malignant neoplasia (Abstract). Lab Invest 50: 13A, 1984.

  66. Sloane BF, Cavanaugh PG, Honn KV: Tumor cysteine proteinases, platelet aggregation and metastasis. In: Honn KV, Sloane BF (eds) Hemostatic mechanisms and metastasis. Martinus Nijhoff, The Hague, 1984, pp 170–191.

    Google Scholar 

  67. Nakajima, Irimura T, DiFerrante D, DiFerrante N, Nicolson GL: Heparan sulfate degradation correlates with tumor invasive and metastatic properties of B16 melanoma sublines. Science 220: 611–613, 1983.

    Google Scholar 

  68. Takenaga K: Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide. Cancer Res 44: 1122–1127, 1984.

    Google Scholar 

  69. Lowe FC, Isaacs JT: Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the Dunning R-3327 rat prostatic adenocarcinoma system as a model. Cancer Res 44: 744–752, 1984.

    Google Scholar 

  70. Bosmann HB, Bieber GF, Brown AE, Case KR, Gersten DM, Kimmerer TW, Lione A: Biochemical parameters correlated with tumor cell implantation. Nature (London) 246: 497–489, 1973.

    Google Scholar 

  71. Nicolson GL, Brunson KL, Fidler IJ: Tumor cell surfaces: some characteristics of neoplastic cells that determine states of transformation and malignancy. Acta Histochem Cytochem 10: 114–133, 1977.

    Google Scholar 

  72. Dolbeare F, Vanderlaan M, Phares M: Alkaline phosphatase and acid arylamidase as marker enzymes for normal and transformed WI-38 cells. J Histochem Cytochem 28: 419–426, 1980.

    Google Scholar 

  73. Morgan RA, Inge KL, Christopher CW: Localization and characterization of N-ethyl maleimide sensitive inhibitor(s) of thiol cathepsin activity from cultured Nil and polyoma virus-transformed Nil hamster cells. J Cell Physiol 108: 55–66, 1981.

    Google Scholar 

  74. Pietras RJ, Szego CM, Roberts JA, Seeler BJ: Lysosomal cathepsin B-like activity: mobilization in prereplicative and neoplastic epithelial cells. J Histochem Cytochem 29: 440–450, 1981.

    Google Scholar 

  75. Burnett D, Crocker J, Vaughn ATM: Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukemia cell line. J Cell Physiol 115: 249–254, 1983.

    Google Scholar 

  76. Miner KM, Kawaguchi T, Uba GW, Nicolson GL: Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo selected, brain meninges-colonizing murine B16 melanoma. Cancer Res 42: 4631–4638, 1982.

    Google Scholar 

  77. Welch DR, Nicolson GL: Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin, 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro. Clin Exp Metastasis 1: 317–325, 1983.

    Google Scholar 

  78. Reznikoff CA, Bertram jS, Brankow DW, Heidelberger C: Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33: 3239–3249, 1973.

    Google Scholar 

  79. Poste G: Methods and models for studying tumor invasion. In: Liotta LA, Hart IR (eds) Tumor invasion and metastasis. Martinus Nijhoff, The Hague, 1982, pp 147–171.

    Google Scholar 

  80. James-Kracke MR, Sloane BF, Shuman H, Somlyo AP: Lysosomal composition in cultured vascular smooth muscle cells: electron probe analysis. Proc Natl Acad Sci USA 76: 6461–6465, 1979.

    Google Scholar 

  81. Ross R, Glomset JA: The pathogenesis of atherosclerosis. N Engl J Med 295: 369–377 and 420–425, 1976.

    Google Scholar 

  82. Fowler S, Shio H, Wolinsky H: Subcellular fractionation and morphology of calf aortic smooth muscle cells. Studies on whole aorta, aortic explants, and subcultures grown under different conditions. J Cell Biol 75: 166–184, 1977.

    Google Scholar 

  83. Kaplan J: Modulation of lysosomal enzyme levels in cultured cells. Effects of alterations in cell density, balanced growth, and endocytosis. Arch Biochem Biophys 187: 376–386, 1978.

    Google Scholar 

  84. Meistrich ML, Grdina DJ, Meyn RE, Barlogie B: Separation of cells from mouse solid tumors by centrifugal elutriation. Cancer Res 37: 4291–4296, 1977.

    Google Scholar 

  85. Meistrich ML, Meyn RE, Barlogie B: Synchronization of mouse L-P59 cells by centrifugal elutriation separation. Exp Cell Res 105: 169–177, 1977.

    Google Scholar 

  86. Bauer KD, Keng PC, Sutherland RM: Isolation of quiescent cells from multicelluar tumor spheroids using centrifugal elutriation. Cancer Res 42: 72–78, 1982.

    Google Scholar 

  87. Talmadge JE, Kay ME, Hart IR: Characterization of a murine ovarian reticulum cell sarcoma of histocytic origin. Cancer Res 41: 1271–1280, 1981.

    Google Scholar 

  88. Labrosse KR, Liener IE: Collagenolytic activities in methylcholanthrene-induced fibrosarcomas in mice. Mol Cell Biochem 19: 181–189, 1978.

    Google Scholar 

  89. Kirschke H, Langner J, Riemann S, Wiederanders B, Bohley P: Cysteine proteinases of lysosomes. In: Strauli P, Barrett AJ, Baici A (eds) Proteinases and tumor invasion. Raven Press, New York, 1980, pp 69–79.

    Google Scholar 

  90. Honn KV, Cavanaugh P, Evens C, Taylor JD, Sloane BF: Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin. Science 217: 540–542, 1982.

    Google Scholar 

  91. Cavanaugh PG, Sloane BF, Bajkowski A, Gasic GJ, Gasic TB, Honn KV: Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin Exp Metastasis 1: 297–308, 1983.

    Google Scholar 

  92. Sloane BF, Sadler JG, Evens C, Ryan R, Bajkowski AS, Crissman JD, Honn KV: Cathepsin B-like cysteine proteinases and tumor metastasis. Cancer Bull, in press.

  93. Graf M, Baici A, Strauli P: Histochemical localization of cathepsin B at the invasion front of the rabbit V2 carcinoma. Lab Invest 45: 587–596, 1981.

    Google Scholar 

  94. Recklies AD, Poole AR, Mort JS: A cysteine proteinase secreted from human breast tumours is immunologically related to cathepsin B. Biochem J 207: 633–636, 1982.

    Google Scholar 

  95. Poole AR, Tiltman KJ, Recklies AD, Stoker TAM: Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (London) 273: 545–547, 1980.

    Google Scholar 

  96. Recklies AD, Tiltman KJ, Stoker TAM, Poole AR: Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res 40: 550–556, 1980.

    Google Scholar 

  97. Rinderknecht J, Renner IG: Increased cathepsin B activity in pancreatic juice from a patient with pancreatic cancer. N Engl J Med 303: 462–463, 1980.

    Google Scholar 

  98. Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM, Orevi M: Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstet Gynecol 52: 321–327, 1978.

    Google Scholar 

  99. Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM: Elevated serum cathepsin B1-like activity in women with neoplastic disease. Gynecol Oncol 7: 1–17, 1979.

    Google Scholar 

  100. Perras RJ, Cramer J, Bishop R, Averette H, Sevin BU: Detection of increased levels of cysteinyl proteinase activity in urine of gynecological cancer patients (Abstract). Proc Am Assoc Cancer Res 24: 130, 1983.

    Google Scholar 

  101. Perras JP, Sevin B-U: Production of monoclonal antibodies against cathepsin B-like enzyme derived from urine of gynecologic cancer patients (Abstract). Proc Am Assoc Cancer Res 25: 250, 1984.

    Google Scholar 

  102. Mangan CE, Flickinger GL, Reed D, Bergantz W, Rubin SI, Mikuta JJ: Levels of urinary cathepsin B like substance in patients with gynecologic malignancy. Am J Clin Oncol, in press.

  103. Recklies AD, Mort JS, Poole AR: Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res 42: 1026–1032, 1982.

    Google Scholar 

  104. Sloane BF, Makim S, Dunn JR, Lacoste R, Theodorou M, Battista J, Alex R, Honn KV: Lipoxygenase products as mediators of tumor cell lysosomal enzyme release: inhibition by nafazatrom. In: Bockman RS, Powles T, Honn KV, Ramwell P (eds) Prostaglandins and cancer. Alan Liss, New York, 1982, pp 789–792.

    Google Scholar 

  105. Mort JS, Leduc M, Recklies AD: A latent thiol proteinase from ascitic fluid of patients with neoplasia. Biochim Biophys Acta 662: 173–180, 1981.

    Google Scholar 

  106. Baici A, Gyger-Marazzi M, Strauli P: Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interaction in the rabbit V2 carcinoma. Invasion Metastasis 4: 13–27, 1984.

    Google Scholar 

  107. Pietras RJ, Roberts JA: Cathepsin B-like enzymes. Subcellular distribution and properties in neoplastic and control cells from human ectocervix. J Biol Chem 256: 8536–8544, 1981.

    Google Scholar 

  108. Bohmer FD, Schmidt HE, Schon R: Proteolytic activities associated with plasma membrane preparations from tumour cells in enzootic bovine leukosis and from normal bovine lymphoid cells. Acta Biol Med Germ 41: 883–890, 1982.

    Google Scholar 

  109. Gasic GJ, Catalfamo JL, Gasic TB, Avdalovic N: In vitro mechanisms of platelet aggregation by purified plasma membrane vesicles shed by mouse 15091A tumor cells. In: Donati MB, Davidson JF, Garattini S (eds) Malignancy and the hemostatic system. Raven Press, New York, 1981, pp 27–35.

    Google Scholar 

  110. Gasic GJ, Boettiger D, Catalfamo JL, Gasic TB, Stewart GJ: Aggregation of platelets and cell membrane vesiculation by rat cells transformed in vitro by Rous sarcoma virus. Cancer Res 38: 2950–2955, 1978.

    Google Scholar 

  111. Poste G, Nicolson GL: Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77: 399–403, 1980.

    Google Scholar 

  112. Kozlowski KA, Wezeman FH, Schultz RM: Tumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe. Proc Natl Acad Sci USA 81: 1135–1139, 1984.

    Google Scholar 

  113. Steven FS, Griffin MM, Itzhaki S, Al-Habib A: A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase. Br J Cancer 42: 712–721, 1980.

    Google Scholar 

  114. Steven FS, Griffin MM, Itzhaki S: Inhibition of free and bound trypsin-like enzymes. Eur J Biochem 126: 311–318, 1982.

    Google Scholar 

  115. Campbell EJ, Senior RM, McDonald JA, Cox DL: Proteolysis by neutrophils. Relative importance of cell-substrate contacts and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest 70: 845–852, 1982.

    Google Scholar 

  116. Mort JS, Leduc M, Recklies AD: Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of cathepsin B. Biochim Biophys Acta 755: 369–375, 1983.

    Google Scholar 

  117. Bajkowski AS, Day NA, Honn KV, Sloane BF: Activation of a cathepsin B-like latent enzyme from cultures of murine B16 amelanotic melanoma (Abstract). Fed Proc Fed Am Soc Exp Biol, in press.

  118. Macartney HW, Tschesche H: Latent collagenase from human polymorphonuclear leukocytes and activation to collagenase by removal of an inhibitor. FEBS Lett 119: 327–332, 1980.

    Google Scholar 

  119. Starkey PM, Barrett AJ: Human cathepsin B1. Inhibition by α2-macroglobulin and other serum proteins. Biochem J 131: 823–831, 1973.

    Google Scholar 

  120. Sasaki M, Taniguchi K, Suzuki K, Imahori K: Human plasma α1- and α2-thiol proteinase inhibitors strongly inhibit Ca-activated neutral protease from muscle. Biochem Biophys Res Commun 110: 256–261, 1983.

    Google Scholar 

  121. Yamamoto RS, Umezawa H, Takeuchi T, Matsushima T, Hara K, Sugimura T: Preventive role of protease inhibitors on lung metastasis of ascites hepatoma. Proc Am Assoc Cancer Res 16: 69, 1975.

    Google Scholar 

  122. Giraldi T, Nisi C, Sava G: Lysosomal enzyme inhibitors and antimetastatic activity in the mouse. Eur J Cancer 13: 1321–1323, 1977.

    Google Scholar 

  123. Sutherland JHR, Greenbaum LM: Paradoxical effect of leupeptin in vivo on cathepsin B activity. Biochem Biophys Res Commun 110: 332–338, 1983.

    Google Scholar 

  124. Umezawa H: Enzyme Inhibitors of Microbial Origin. University of Tokyo Press, Tokyo, 1972, pp 15–52.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Wayne State University, 48201, Detroit, MI, USA

    Bonnie F. Sloane

  2. Department of Radiation Oncology, Wayne State University, 48201, Detroit, MI, USA

    Bonnie F. Sloane & Kenneth V. Honn

  3. Department of Biological Sciences, Wayne State University, 48201, Detroit, MI, USA

    Kenneth V. Honn

Authors
  1. Bonnie F. Sloane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth V. Honn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sloane, B.F., Honn, K.V. Cysteine proteinases and metastasis. Cancer Metast Rev 3, 249–263 (1984). https://doi.org/10.1007/BF00048388

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00048388

Keywords

Search

Navigation